Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report.

Author: AdetulaItioye, BoaduCharles, FrunziJohnathan, HernandezAndrea, ZeidanBassem S

Paper Details 
Original Abstract of the Article :
Acute pancreatitis is an acute inflammatory process of the pancreas that is associated with multiple etiologies. The two most common causes are gallstones and acute alcohol intoxication. However, medications are often overlooked when determining the cause. Empagliflozin is a type of sodium-glucose t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837635/

データ提供:米国国立医学図書館(NLM)

Empagliflozin-Related Acute Pancreatitis: A Case Report

This case report explores a rare side effect associated with empagliflozin, a medication used to treat type 2 diabetes mellitus. The authors, like detectives investigating a medical mystery, describe the case of a 64-year-old woman who developed acute pancreatitis after initiating empagliflozin treatment. The report highlights the importance of considering medications as a potential cause of acute pancreatitis, especially with newly introduced drugs. The case underscores the need for continued monitoring and reporting of adverse events associated with medications.

Uncovering the Hidden Risks of Diabetes Medications

This case report, like a hidden oasis in a vast desert, reveals a previously unrecognized side effect of empagliflozin, prompting a deeper understanding of the potential risks associated with diabetes medications.

Navigating the World of Diabetes Medications

The report underscores the importance of being aware of the potential side effects of medications, especially newer drugs like empagliflozin, and reporting any unusual symptoms to healthcare providers.

Dr.Camel's Conclusion

This case report serves as a reminder that even seemingly safe medications can have unexpected side effects.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-02-02
Further Info :

Pubmed ID

33520523

DOI: Digital Object Identifier

PMC7837635

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.